Author

Martin van Hagen

Observed names: M. V. Hagen, M. van Hagen, Martin Van Hagen

Institutions: Chulalongkorn University, Erasmus MC, University of Indonesia

Observed institutions: Chulalongkorn University, Erasmus MC, University of Indonesia, Academisch Ziekenhuis Rotterdam

OpenAlex ID: A5111400975

2016 · Faiz Karim, Jan Loeffen, et al. · Pediatric Rheumatology · 178

Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections

2017 · Marjolein Wentink, Virgil Dalm, et al. · Clinical Immunology · 97

Hyper‐IgE in the allergy clinic––when is it primary immunodeficiency?

2018 · Mark J. Ponsford, Adam Klocperk, et al. · Allergy · 58

PDF

Radiolabeled RGD-DTPA-Tyr 3 -Octreotate for Receptor-Targeted Radionuclide Therapy

2004 · Bert Bernard, Astrid Capello, et al. · Cancer Biotherapy and Radiopharmaceuticals · 36

Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients

2020 · Tim B van der Houwen, Willem A Dik, et al. · Rheumatology · 22

PDF

2017 · Faiz Karim, Joeri de Hoog, et al. · Acta Ophthalmologica · 19

PDF

2019 · Sanne Emilie Detiger, Faiz Karim, et al. · World Neurosurgery · 18

Granulomas in Common Variable Immunodeficiency Display Different Histopathological Features Compared to Other Granulomatous Diseases

2024 · Astrid C. van Stigt, Jan H. von der Thüsen, et al. · Journal of Clinical Immunology · 11

PDF

Evaluation of a radiolabeled cyclic DTPA-RGD analog for tumor imaging and radionuclide therapy

2000 · M. de Jong, M. van Hagen, et al. · Nuclear Medicine Communications · 10

The PID Odyssey 2030: outlooks, unmet needs, hurdles, and opportunities — proceedings from the IPOPI global multi-stakeholders’ summit (June 2022)

2023 · Susan Tadros, Johan Prévot, et al. · Frontiers in Immunology · 9

PDF

Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023)

2024 · Samya Van Coillie, Johan Prévot, et al. · Frontiers in Immunology · 7

PDF

Immune-mediated inflammatory diseases: a new multidisciplinary concept.

2009 · Dominique Baeten, Martin van Hagen, et al. · PubMed · 5

Tissue IgG2/IgG4 Ratio as an Additional Tool to Distinguish IgG4-Related Disease From Other Fibroinflammatory Disorders

2022 · Sanne E. Detiger, Dion Paridaens, et al. · Applied immunohistochemistry & molecular morphology · 4

Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years

2025 · Lúcia Mamede, Roser Cantenys Sabà, et al. · Frontiers in Immunology · 3

PDF

Immunotherapy for rapid bone marrow conditioning and leukemia depletion that allows efficient hematopoietic stem cell transplantation

2025 · Giada Dal Collo, Srdjan Grusanovic, et al. · Journal for ImmunoTherapy of Cancer · 2

PDF

Research on the health impact of climate must consider distributive justice and environmental sustainability

2024 · Cristina Richie, Pilar Garcia-Gomez, et al. · PLOS Climate · 2

Improvement of Recurrent Infections after IVIG Supplementation in a Patient with Leukocyte Adhesion Deficiency III with a Novel Missense Mutation in FERMT3

2015 · Narissara Suratannon, Patra Yeetong, et al. · Journal of Allergy and Clinical Immunology · 2

Microarray Bioinformatics

2018 · Narissara Suratannon, Martin van Hagen, et al. · Wiley eBooks · 1

FcRn mediated IgG transport by retinal pigment epithelium cells

2012 · Nicoline M Korthagen, Kiki van Bilsen, et al. · Journal of Translational Medicine · 1

PDF

Somatostatin and substance P analogues: applications in autoimmune and haematological diseases

1995 · Martin van Hagen · 1

Immunologic mechanisms associated with STAT6 gain-of-function variant identified in early-onset allergies

2024 · Narissara Suratannon, Willem Dik, et al. · Journal of Allergy and Clinical Immunology

PDF

IgG4-gerelateerde ziekte: huidige stand van zaken = IgG4-related disease: current situation

2018 · Faiz Karim, M A W Hermans, et al. · EUR Research Repository (Erasmus University Rotterdam)

A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in Europe and North America

2017 · Daniel Suez, Gregely Krivan, et al. · Journal of Allergy and Clinical Immunology

Systemische mastocytose: een heterogene ziekte

2016 · Maud A.W. Hermans, Maurice Verburg, et al. · Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank

Mutations in MVK cause non-syndromic autosomal recessive retinitis pigmentosa

2013 · Anna M. Siemiatkowska, Monique Stoffels, et al. · Investigative Ophthalmology & Visual Science

Works count: 30

Citation count: 486

H-index: 9

I10-index: 9